Skip to main content
. 2018 Mar 30;7(5):2021–2033. doi: 10.1002/cam4.1468

Figure 6.

Figure 6

The pathway of RFX1 participating in the doxorubicin‐induced direct promotion of HBV replication. Doxorubicin promotes RFX1 expression and increases the amount of RFX1 bound to the EP element of HBV enhancer I. Subsequently, the activity of HBV enhancer I is enhanced, and HBV replication is promoted.